GNI Group Ltd
3G6
Company Profile
Business description
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Contact
2-2-2 Nihonbashi Honcho
3rd Floor, Nihonbashi Honcho YS Building
Chuo-ku
Tokyo103-0023
JPNT: +81 362143600
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,040
Stocks News & Analysis
stocks
Margins have bottomed for ASX listed consumer goods company
Impact of tariffs have been priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,016.40 | 33.30 | -0.37% |
| CAC 40 | 8,400.11 | 21.03 | -0.25% |
| DAX 40 | 25,139.69 | 153.87 | 0.62% |
| Dow JONES (US) | 51,712.71 | 148.01 | 0.29% |
| FTSE 100 | 10,437.85 | 74.58 | 0.72% |
| HKSE | 23,767.87 | 0.65 | -0.00% |
| NASDAQ | 26,166.60 | 351.33 | -1.32% |
| Nikkei 225 | 71,690.37 | 663.59 | -0.92% |
| NZX 50 Index | 13,481.07 | 35.02 | 0.26% |
| S&P 500 | 7,472.79 | 27.79 | -0.37% |
| S&P/ASX 200 | 8,811.20 | 23.90 | -0.27% |
| SSE Composite Index | 4,166.47 | 3.38 | 0.08% |